Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Induction of the iron regulatory hormone hepcidin contributes to the anemia of inflammation. Bone morphogenetic protein 6 (BMP6) signaling is a central regulator of hepcidin expression in the liver. Recently, the TGF-β/BMP superfamily member activin B was implicated in hepcidin induction by inflammation via noncanonical SMAD1/5/8 signaling, but its mechanism of action and functional significance in vivo remain uncertain. Here, we show that low concentrations of activin B, but not activin A, stimulate prolonged SMAD1/5/8 signaling and hepcidin expression in liver cells to a similar degree as canonical SMAD2/3 signaling, and with similar or modestly reduced potency compared with BMP6. Activin B stimulates hepcidin via classical activin type II receptors ACVR2A and ACVR2B, noncanonical BMP type I receptors activin receptor-like kinase 2 and activin receptor-like kinase 3, and SMAD5. The coreceptor hemojuvelin binds to activin B and facilitates activin B-SMAD1/5/8 signaling. Activin B-SMAD1/5/8 signaling has some selectivity for hepatocyte-derived cells and is not enabled by hemojuvelin in other cell types. Liver activin B mRNA expression is up-regulated in multiple mouse models of inflammation associated with increased hepcidin and hypoferremia, including lipopolysaccharide, turpentine, and heat-killed Brucella abortus models. Finally, the activin inhibitor follistatin-315 blunts hepcidin induction by lipopolysaccharide or B. abortus in mice. Our data elucidate a novel mechanism for noncanonical SMAD activation and support a likely functional role for activin B in hepcidin stimulation during inflammation in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, inflammation also feeds into the BMP6 signaling pathway, adding further complexity; not only to the regulation of iron homeostasis, but also to the pathophysiology of AI and the clinical interpretation of iron indices [72].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA
Rasband, W. S. (2011) · Medical Entomology and Zoology · Cited by 1,221
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors
Goumans, M.-J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,123
Ganz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Self-citationBone morphogenetic protein receptors and signal transduction
Miyazono, K., Kamiya, Y., & Morikawa, M. (2010) · Journal of Biochemistry · doi:10.1093/jb/mvp148 · Cited by 999
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 881
Research works printed but not linked: 1
- 30. WrightonKH,LinX,YuPB,FengXH. Transforming growth factor 𝛃 canstimulateSmad1phosphorylationindependentlyofbonemorphogenic protein receptors. J Biol Chem . 2009;284(15):97559763.
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Liver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360
Self-citationIron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
The multifaceted role of iron in renal health and disease
van Swelm, R. P. L., Wetzels, J. F. M., & Swinkels, D. W. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0197-5 · Cited by 275
Iron and liver fibrosis: Mechanistic and clinical aspects
Mehta, K. J., Farnaud, S. J., & Sharp, P. A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i5.521 · Cited by 269
Hepcidin regulation in the anemia of inflammation
Wang, C.-Y., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 250
Self-citationTransforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
Jung, B., Staudacher, J. J., & Beauchamp, D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.015 · Cited by 241
Asshoff, M., Petzer, V., Warr, M. R., Haschka, D., Tymoszuk, P., Demetz, E., Seifert, M., Posch, W., Nairz, M., Maciejewski, P., et al. (2017) · Blood · doi:10.1182/blood-2016-09-740092 · Cited by 233
“Activin B, belonging to the TGF-b protein superfamily, has been reported to activate the SMAD1/5/8 pathway and induce Hamp expression, at least in vitro.(29) Although Inhibin BBmRNA levels in the liver ofACD rats decreasedwithMMB treatment for 3 days, levels remained above baseline and did not show a clear dose-depend…”
Fraenkel, P. G. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.09.005 · Cited by 192
“Activin B has been shown to increase hepcidin transcription in cultured hepatocytes in vitro via Smad signaling [42].”
BackgroundEndothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice
Canali, S., Zumbrennen-Bullough, K. B., Core, A. B., Wang, C.-Y., Nairz, M., Bouley, R., Swirski, F. K., & Babitt, J. L. (2017) · Blood · doi:10.1182/blood-2016-06-721571 · Cited by 212
Self-citationLanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 211
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6
Canali, S., Wang, C., Zumbrennen‐Bullough, K. B., Bayer, A., & Babitt, J. L. (2017) · American Journal of Hematology · doi:10.1002/ajh.24888 · Cited by 133
“Antibodies were verified previously.(26) Membranes were washed,”
MethodSelf-citationHepcidin: A Promising Therapeutic Target for Iron Disorders A Systematic Review
Liu, J. L., Sun, B., Yin, H.-J., & Liu, S. (2016) · Medicine · doi:10.1097/md.0000000000003150 · Cited by 156
Iron and innate antimicrobial immunity-depriving the pathogen, defending the host
Nairz, M., Dichtl, S., Schroll, A., Haschka, D., Tymoszuk, P., Theurl, I., & Weiss, G. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.03.007 · Cited by 123
Systemic iron homeostasis and erythropoiesis
Papanikolaou, G. V., & Pantopoulos, K. (2017) · IUBMB Life · doi:10.1002/iub.1629 · Cited by 146
“Consistently, it has been proposed that HFE stimulates iron signaling by stabilizing the type I BMP receptor ALK3 (74).”
BackgroundInfluentialReceptor binding competition: A paradigm for regulating TGF-β family action
Martinez-Hackert, E., Sundan, A., & Holien, T. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.09.003 · Cited by 89
Bone morphogenic proteins in iron homeostasis
Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 94
“Activin B-SMAD1/5/8 signaling is mediated by BMP type I receptors ALK2 and ALK3 and is selective for hepatocytes, since it was not seen in several other cell lines tested [29].”
BackgroundSelf-citationSmad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice
Wang, C.-Y., Core, A. B., Canali, S., Zumbrennen-Bullough, K. B., Ozer, S., Umans, L., Zwijsen, A., & Babitt, J. L. (2017) · Blood · doi:10.1182/blood-2016-12-759423 · Cited by 86
Self-citationRegulators of hepcidin expression
Roth, M., Meynard, D., & Coppin, H. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.005 · Cited by 97
Therapeutic potential of hepcidin − the master regulator of iron metabolism
Vyoral, D., & Petrák, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.010 · Cited by 85
Fillebeen, C., Wilkinson, N., Charlebois, E., Katsarou, A., Wagner, J., & Pantopoulos, K. (2018) · Blood · doi:10.1182/blood-2018-03-841197 · Cited by 78
“There is increasing evidence for crosstalk between the iron and inflammatory pathways(4,5) but the molecular mechanisms are not well understood.(6,7) HJV operates as a BMP co-receptor and is essential for iron-dependent regulation of hepcidin.”
InfluentialStructural perspective of BMP ligands and signaling
Gipson, G. R., Goebel, E. J., Hart, K. N., Kappes, E. C., Kattamuri, C., McCoy, J. C., & Thompson, T. B. (2020) · Bone · doi:10.1016/j.bone.2020.115549 · Cited by 70
Armitage, A. E., & Moretti, D. (2019) · Pharmaceuticals · doi:10.3390/ph12020059 · Cited by 88
Vela, D. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0008-7 · Cited by 71
“Inflammation induces hepcidin expression through janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, though SMAD pathway has been shown to be affected during inflammation as well (Wrighting and Andrews 2006; Canali et al. 2016).”
BackgroundTherapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 65
“Activin B interacts with type 2 BMPR ActR2A and type 1 receptors ALK2 and ALK3 to stimulate hepcidin expression via SMAD1/5/8 phosphorylation as described above [30,31].”
BackgroundMethodColucci, S., Pagani, A., Pettinato, M., Artuso, I., Nai, A., Camaschella, C., & Silvestri, L. (2017) · Blood · doi:10.1182/blood-2017-04-780692 · Cited by 62
“ActivinA, a critical component of the inflammatory response, secreted in the circulation, was not previously reported to take part in hepcidin activation.(39,42) Activin A binds BMPR-II, ACVR2A and ACVR2B, and the BMPR-I ALK4.”
BackgroundOlsen, O. E., Hella, H., Elsaadi, S., Jacobi, C., Martínez-Hackert, E., & Holien, T. (2020) · Biomolecules · doi:10.3390/biom10040519 · Cited by 65
Shonibare, Z., Monavarian, M., O’Connell, K. M., Altomare, D., Shelton, A., Mehta, S., Jaskula‐Sztul, R., Phaëton, R., Starr, M. D., Whitaker, R. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111066 · Cited by 57
BMPR2 inhibits activin and BMP signaling via wild-type ALK2
Olsen, O. E., Sankar, M., Elsaadi, S., Hella, H., Buene, G., Darvekar, S. R., Misund, K., Katagiri, T., Knaus, P. I., & Holien, T. (2018) · Journal of Cell Science · doi:10.1242/jcs.213512 · Cited by 56
“Also, in hepatocytes, knockdown of BMPR2 potentiated BMP6- and activin B-induced SMAD1/5/8 activity (Canali et al., 2016).”
BackgroundIron and inflammation – the gut reaction
Verma, S., & Cherayil, B. J. (2017) · Metallomics · doi:10.1039/c6mt00282j · Cited by 52
Regulation of hepcidin expression by inflammation-induced activin B
Kanamori, Y., Sugiyama, M., Hashimoto, O., Murakami, M., Matsui, T., & Funaba, M. (2016) · Scientific Reports · doi:10.1038/srep38702 · Cited by 50
Varga, E., Pap, R., Jánosa, G., Sipos, K., & Pandur, E. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03322-0 · Cited by 65
“Recent studies demonstrate that there is a possible crosstalk between the BMP/SMAD and the IL-6 mediated JAK/STAT3 pathway at inflammation in hepatoma cell lines and primary mouse hepatocytes [48, 49].”
BackgroundLatour, C., Besson-Fournier, C., Gourbeyre, O., Meynard, D., Roth, M.-P., & Coppin, H. (2017) · Blood · doi:10.1182/blood-2017-07-795658 · Cited by 48
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
van Vuren, A. J., Gaillard, S., Eisenga, M. F., van Wijk, R., & van Beers, E. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00304 · Cited by 48
Shaping the bone through iron and iron-related proteins
Ledesma-Colunga, M. G., Weidner, H., Spasić, M. V., Hofbauer, L. C., Baschant, U., & Rauner, M. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.06.002 · Cited by 53
Enculescu, M., Metzendorf, C., Sparla, R., Hahnel, M. J., Bode, J. G., Muckenthaler, M. U., & Legewie, S. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005322 · Cited by 51
Wang, C., Xiao, X., Bayer, A. L., Xu, Y., Dev, S., Canali, S., Nair, A. V., Masia, R., & Babitt, J. L. (2019) · Hepatology · doi:10.1002/hep.30780 · Cited by 49
“BMP R-SMAD phosphorylation is also activated by inflammation (18, 19), and inhibiting BMP-SMAD signaling lowers hepcidin in the context of inflammation (20-23), suggesting crosstalk between the IL-6-STAT3 and BMP-SMAD pathways.”
Self-citationBalance of cardiac and systemic hepcidin and its role in heart physiology and pathology
Vela, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.111 · Cited by 44
Advances in understanding iron metabolism and its crosstalk with erythropoiesis
Camaschella, C., & Pagani, A. (2018) · British Journal of Haematology · doi:10.1111/bjh.15403 · Cited by 49
Fisher, A. L., & Babitt, J. L. (2021) · Developmental Dynamics · doi:10.1002/dvdy.372 · Cited by 43
Self-citationActivin receptor-like kinases: a diverse family playing an important role in cancer.
Loomans-Kropp, H. A., & Andl, C. D. (2016) · PubMed · Cited by 39
Treatment of anemia in difficult-to-manage patients with chronic kidney disease
Raichoudhury, R., & Spinowitz, B. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.006 · Cited by 47
“deficiency may be caused by increased hepcidin production,(9,11) which is stimulated by proinflammatory cytokines.(12,13) Elevated hepcidin levels promote sequestration of”
BackgroundTGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis
Kahata, K., Maturi, V., & Moustakas, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a031997 · Cited by 43
“Activin B also binds to RGMc in the liver, mediating signaling through ActRII and ActRIIB and the type I receptors BMPRIA and ActRI, which activate Smad5 and enhance hepcidin expression (Canali et al. 2016).”
BackgroundHepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B
Besson‐Fournier, C., Gineste, A., Latour, C., Gourbeyre, O., Meynard, D., Martín, P., Oswald, É., Coppin, H., & Roth, M. (2016) · Blood · doi:10.1182/blood-2016-10-748541 · Cited by 42
The SMAD Pathway Is Required for Hepcidin Response During Endoplasmic Reticulum Stress
Canali, S., Vecchi, C., Garuti, C., Montosi, G., Babitt, J. L., & Pietrangelo, A. (2016) · Endocrinology · doi:10.1210/en.2016-1258 · Cited by 34
Self-citationDoes Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?
da Silva, I. S., Rausch, V., Seitz, H. K., & Mueller, S. (2017) · Cancers · doi:10.3390/cancers9110145 · Cited by 31
Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis
Mueller, S., Chen, C., Mueller, J. H., & Wang, S. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0056 · Cited by 34
20 years of Hepcidin: How far we have come
Colucci, S., Marques, O., & Altamura, S. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.001 · Cited by 30
Hypoferremia of inflammation: Innate host defense against infections
Ganz, T., & Nemeth, E. (2023) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102777 · Cited by 33
Extrahepatic hepcidin production: The intriguing outcomes of recent years
Daher, R., Lefèbvre, T., Puy, H., & Karim, Z. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i15.1926 · Cited by 29
Iron Mining for Erythropoiesis
Correnti, M., Gammella, E., Cairo, G., & Recalcati, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105341 · Cited by 33
“At the molecular level, hepcidin is induced by inflammatory mediators, in particular interleukin 6 (IL-6) [40], which triggers hepcidin transcription mainly via the JAK–STAT3 signaling pathway, though inflammation may stimulate hepcidin also through TGF-β/BMP superfamily ligands, such as Activin B [41].”
BackgroundIron metabolism and chronic inflammation in IgA nephropathy
Tian, Z.-Y., Li, Z., Chu, L., Liu, Y., He, J., Yu, X., Li, A., & Zhang, H. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2195012 · Cited by 26
Signaling pathways regulating hepcidin
Rishi, G., & Subramaniam, V. N. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.003 · Cited by 24
The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer
Moradi‐Marjaneh, R., Khazaei, M., Ferns, G. A., & Aghaee‐Bakhtiari, S. H. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190110150705 · Cited by 22
Enns, C. A., Jue, S. F., & Zhang, A. (2021) · Blood · doi:10.1182/blood.2020009485 · Cited by 23
Role of Activins in Hepcidin Regulation during Malaria
Spottiswoode, N., Armitage, A. E., Williams, A. R., Fyfe, A. J., Biswas, S., Hodgson, S. H. C., Llewellyn, D., Choudhary, P., Draper, S. J., Duffy, P. E., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00191-17 · Cited by 22
“abrogation of hepcidin upregulation after LPS challenge by use of the activin-binding protein follistatin (32).”
InfluentialRana, S., & Prabhakar, N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.032 · Cited by 26
Cardiac iron metabolism during aging – Role of inflammation and proteolysis
Walter, S., Mertens, C., Muckenthaler, M. U., & Ott, C. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111869 · Cited by 20
Fu, S., Huang, J., Feng, Z., Wang, H., Xu, H., Wu, M., Ma, F., & Xu, Z. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2399314 · Cited by 25
“…nevertheless, these cells also respond to microbial, autoantigen, or tumor antigen exposures, immune cells release a variety of inflammatory cytokines and affect iron metabolism [42]. il-1 and il-6 can affect iron homeostasis by influencing heparin formation and stimulating Hb synthesis [43].”
Lidbury, B. A., Kita, B., Richardson, A., Lewis, D. P., Privitera, E., Hayward, S., de Kretser, D., & Hedger, M. P. (2019) · Diagnostics · doi:10.3390/diagnostics9030079 · Cited by 21
“Separating the specific biology of activin B from the well-studied roles of activin A has shown insights in relation to SMAD signalling [10,39,40], which will further illuminate activin B utility in the context of ME/CFS.”
BackgroundDavaanyam, D., Seol, S.-I., Oh, S.-A., Lee, H., & Lee, J.-K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01314-y · Cited by 24
Vela, D., Sopi, R., & Mladenov, M. I. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.04.007 · Cited by 22
Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
Ryanto, G. R. T., Musthafa, A., Hara, T., & Emoto, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043332 · Cited by 19
“There is evidence that activin B can bind to ActRIIB or ActRIIA with non-canonical type I receptors known as ALK2 or ALK3, also known as the BMP type I receptor [58,59].”
The role of heparin, heparanase and heparan sulfates in hepcidin regulation
Asperti, M., Denardo, A., Gryzik, M., Arosio, P., & Poli, M. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.008 · Cited by 18
Refaat, B., Zekri, J., Aslam, A., Ahmad, J., Baghdadi, M. A., Meliti, A., Idris, S., Sultan, S., Alardati, H. A., Saimeh, H. A., et al. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1610032 · Cited by 16
“Act-AB could also mediate its actions using Smads 1/ 5/8 [38, 43, 44], the main mediators of the bone morphogenic proteins that act as tumour suppressors in CRC [45, 46].”
BackgroundActivin B promotes the initiation and progression of liver fibrosis
Wang, Y., Hamang, M., Culver, A. E., Jiang, H., Yanum, J. A., Garcia, V., Lee, J., White, E., Kusumanchi, P., Chalasani, N., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2037 · Cited by 18
Layoun, A., Samba-Mondonga, M., Fragoso, G., Calvé, A., & Santos, M. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00159 · Cited by 16
“In fact, stimulation of SMAD1/5/8 signaling and hepcidin induction during inflammation by other TGF-β superfamily members, such as activin B (Besson-Fournier et al., 2012), has been shown to be unique in liver cells (Canali et al., 2016).”
BackgroundLiu, S., Tsyplenkova, S., Fillebeen, C., & Pantopoulos, K. (2025) · American Journal of Hematology · doi:10.1002/ajh.27710 · Cited by 15
“However, this is not accompanied by a similar drop in Hjv protein levels [45] and, therefore, hepcidin induction is not affected [7].”
Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications
Du, R., Wen, L., Niu, M., Zhao, L., Guan, X., Jiao, Y., Zhang, C., & Liu, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116061 · Cited by 18
Dual role of hepcidin in response to pathogens
Navidifar, T., Meftah, E., Baghsheikhi, H., Kazemzadeh, K., Karimi, H., & Rezaei, N. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107496 · Cited by 16
MyD88 Regulates the Expression of SMAD4 and the Iron Regulatory Hormone Hepcidin
Samba-Mondonga, M., Calvé, A., Mallette, F. A., & Santos, M. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00105 · Cited by 10
“, 2017) and the peptide hormone Activin B have also been shown to induce hepcidin expression through SMAD1/5/8 signaling (Besson-Fournier et al., 2012; Canali et al., 2016).”
BackgroundInhibin subunit beta B (INHBB): an emerging role in tumor progression
Liu, Y., Zhou, Q. T., Zou, G., & Zhang, W. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01041-y · Cited by 12
“Activin B signaling activates SMAD 1/5/8 signal and hepcidin expression through its typical type II receptor, binding to BMP I receptor and co-receptor HJV [ 18 ].”
Li, L., Wang, X., Zhang, H., Chen, Q., & Cui, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173958 · Cited by 10
Ham, S. Y., Jun, J. H., Kim, H.-B., Shim, J., Lee, G., & Kwak, Y. L. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121124 · Cited by 7
Evolving roles of activins and inhibins in ovarian cancer pathophysiology
Evans, E., Horst, B., Arend, R. C., & Mythreye, K. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00178.2022 · Cited by 7
Influence of Hepcidin in the Development of Anemia
Reichert, C. O., Marafon, F., Levy, D., Maselli, L. M. F., Bagatini, M. D., Blatt, S. L., Bydlowski, S. P., & Spada, C. (2018) · InTech eBooks · doi:10.5772/intechopen.71476 · Cited by 10
Saadh, M. J., Allela, O. Q. B., Sattay, Z. J., Zuhairi, R. A. H. A., Ahmad, H., Eldesoky, G. E., Adil, M., & Ali, M. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155158 · Cited by 6
Transcriptional activation of hepcidin by the microphthalmia/transcription factor E family
Matsumura, M., Murakami, M., & Funaba, M. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3739 · Cited by 8
“Furthermore, activin B stimulates hepcidin transcription via BMP‐REs.(17,18)”
BackgroundIron chelation for the treatment of uveitis
Chen, J., Zhou, J., Kelly, M. E. M., Holbein, B. E., & Lehmann, C. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.03.029 · Cited by 6
Xin, X., Chang, H., Leung, P. C. K., Dong, L., Li, J., Lian, F., & Wu, H. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02972-z · Cited by 5
“Previous studies have suggested that BMP6 may induce the activation of downstream SMAD1/5/8 proteins [34].”
BackgroundNugraha, G., Widjiati, W., Aryati, A., Wungu, C. D. K., Notopuro, H., Darmanto, W., Sulistyono, A., Notobroto, H. B., & Rejeki, P. S. (2024) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/9zaep69ner · Cited by 4
Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance
Kobayashi, N., Okazaki, Y., Iwane, A., Hara, K., Horikoshi, M., Awazawa, M., Soeda, K., Matsushita, M., Sasako, T., Yoshimura, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58836-w · Cited by 4
Metzendorf, C., Zeigerer, A., Seifert, S., Sparla, R., Najafi, B., Canonne‐Hergaux, F., Zerial, M., & Muckenthaler, M. U. (2017) · Scientific Reports · doi:10.1038/s41598-017-02898-4 · Cited by 4
Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice
PATEL, V. G., Joharapurkar, A. A., Kshirsagar, S. G., Patel, M. S., Patel, H., Savsani, H. H., & Jain, M. R. (2021) · Drug Research · doi:10.1055/a-1542-8531 · Cited by 5
“LPS decreases serum iron by inducing hepcidin through IL-6 and BMP signaling [21, 22].”
BackgroundLuo, M., Liu, Q., Ye, S., Liu, S., Hu, Y., Lv, D., Wang, G., Li, M., Jian, C., & Huang, B. (2021) · Research in Veterinary Science · doi:10.1016/j.rvsc.2021.11.008 · Cited by 5
Weiler, S., & Nairz, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627223 · Cited by 4
Releasing the FKBP12 brake on hepcidin
Parrow, N. L., & Fleming, R. E. (2017) · Blood · doi:10.1182/blood-2017-09-805390 · Cited by 3
“Studies using follistatin (an activin A and B inhibitor) in murine models of acute and chronic inflammation have suggested a role for one or both of these cytokines in hepcidin regulation.(6) Subsequent studies have not supported a role for activin B.”
BackgroundExpression of iron regulatory proteins in full‐term swine placenta
Rajamanickam, K., Leela, V., Suganya, G., Basha, S. H., Parthiban, M., Pazhanivel, N., & Gowri, A. M. (2020) · Reproduction in Domestic Animals · doi:10.1111/rda.13730 · Cited by 3
Mueller, S., Mueller, J. H., Li, S., Zheng, C., & Chen, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_57 · Cited by 2
Advances in iron homeostasis and ferromagnetic nanoparticles
Wang, J., An, P., Wang, H., Wu, Q., Fang, X., Min, J., & Wang, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00707
Factors affecting the induction of uncoupling protein 1 in C2C12 myogenic cells
Yamamoto, T., Diao, Z., Murakami, M., Shimokawa, F., Matsui, T., & Funaba, M. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155936 · Cited by 2
Anemia of inflammatory: does eiderr knowledge mean better diagnosis and treatment?
Tupý, J. (2023) · Vnitřní lékařství · doi:10.36290/vnl.2023.023 · Cited by 2
Elhussain, K. M. K., Abdelrhman, A. H., & Abdelgader, E. A. (2020) · International Journal of Clinical and Experimental Medicine Research · doi:10.26855/ijcemr.2020.07.001 · Cited by 1
“Other cytokines, including IL-1 and activin B, can also stimulate hepcidin production, but their specific pathological role is less well established [6].”
BackgroundSanyear, C., Chiawtada, B., Butthep, P., Svasti, S., Fucharoen, S., & Masaratana, P. (2021) · PeerJ · doi:10.7717/peerj.11367
“Notably, the crosstalk between the BMP-SMAD and JAK-STAT pathways relative to the regulation of hepcidin expression has previously been reported (Besson-Fournier et al., 2012; Canali et al., 2016; Fillebeen et al., 2018; Gallitz et al., 2018; Verga Falzacappa et al., 2008; Yu et al., 2008; Steinbicker et al., 2011; De…”
Identification and analysis of genetic and chemical modulators of iron metabolism
Hawula, Z. J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.225904 · Cited by 1
Hereditary anemias: more complex than ever
van Vuren, A. J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/429
Metadata
- Authors
- Canali, S., Core, A. B., Zumbrennen-Bullough, K. B., Merkulova, M., Wang, C.-Y., Schneyer, A. L., Pietrangelo, A., & Babitt, J. L.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Harvard University (US)
- Program in Anemia Signaling Research (S.C., A.B.C., K.B.Z.-B., M.M., C.-Y.W., J.L.B.), Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
- University of Massachusetts Amherst (US)
- Corresponding author
- Babitt, Jodie L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2016-01-06
- Volume
- 157
- Issue
- 3
- Pages
- 1146-1162
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC4769363
- OpenAlex
- W2231572828
- Cited by
- 113
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 19 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 20 · 2016: 11
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- Massachusetts General Hospital
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007540, R01DK087727)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- activin B, hepcidin, BMP type I receptor, hepatocytes, inflammation, anemia of chronic disease, hemojuvelin, ACVR2A, ACVR2B, ALK2, ALK3, Smad5, BMP6, lipopolysaccharide, Brucella abortus, hypoferremia
- MeSH terms
- Animals, Humans, Inflammation, Male, Immunoblotting, Signal Transduction, Reverse Transcriptase Polymerase Chain Reaction, Surface Plasmon Resonance, Hepatocytes, Activins, Cell Line, Tumor, Mice, Smad1 Protein, Smad5 Protein, Smad8 Protein, Bone Morphogenetic Protein Receptors, Type I, Real-Time Polymerase Chain Reaction, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.